Provided by Tiger Trade Technology Pte. Ltd.

Collegium Pharmaceutical

22.75
-0.1700-0.74%
Post-market: 22.800.0500+0.22%19:30 EDT
Volume:661.30K
Turnover:15.11M
Market Cap:740.64M
PE:17.91
High:23.25
Open:23.02
Low:22.64
Close:22.92
52wk High:50.79
52wk Low:22.64
Shares:32.56M
Float Shares:31.37M
Volume Ratio:0.68
T/O Rate:2.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.73
ROE:17.61%
ROA:5.75%
PB:2.37
PE(LYR):13.15

Loading ...

Leerink Partners Initiates Coverage on Collegium Pharmaceutical With Outperform Rating, $45 Price Target

MT Newswires Live
·
Sep 09

Truist Cuts Price Target on Collegium Pharmaceutical to $49 From $58, Keeps Buy Rating

MT Newswires Live
·
Sep 09

Analysts Offer Insights on Healthcare Companies: Collegium Pharmaceutical (COLL), Revolution Medicines (RVMD) and Intellia Therapeutics (NTLA)

TIPRANKS
·
Sep 09

Collegium Pharmaceutical, Inc. : Leerink Partners Initiates Coverage with Outperform Rating; Price Target $45

THOMSON REUTERS
·
Sep 09

Collegium Pharmaceutical assumed with a Buy at Truist

TIPRANKS
·
Sep 09

U.S. Research Roundup-Argan, Mastec, Oracle

Reuters
·
Sep 09

Collegium Pharmaceutical is Maintained at Overweight by Barclays

Dow Jones
·
Aug 19

Barclays Sticks to Their Buy Rating for Collegium Pharmaceutical (COLL)

TIPRANKS
·
Aug 19

Collegium Pharmaceutical Enters $50 Million Accelerated Share Repurchase Agreement

MT Newswires Live
·
Aug 13

Collegium Announces $50 Million Accelerated Share Repurchase Program

THOMSON REUTERS
·
Aug 13

Collegium Pharmaceutical Price Target Cut to $43.00/Share from $45.00 by Piper Sandler

Dow Jones
·
Aug 08

U.S. Research Roundup-Airbnb, Expedia Group, Parker-Hannifin

Reuters
·
Aug 07

Analysts’ Top Healthcare Picks: Collegium Pharmaceutical (COLL), Adicet Bio (ACET)

TIPRANKS
·
Aug 07

Collegium Pharmaceutical Down over 13%, on Track for Largest Percent Decrease Since May 2024

Dow Jones
·
Aug 06

Collegium Pharmaceutical Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Collegium Pharmaceutical Updates Guidance After AZSTARYS Acquisition

TIPRANKS
·
Aug 06

GUIDANCE: (COLL) Collegium Pharmaceutical Expects 2026 Net Product Revenue Range $825M to $855M

MT Newswires Live
·
Aug 06

Collegium Turns to GAAP Net Loss of $15.1 Million in Q2 FY26; Revenue Rises 6% to $199.9 Million

Reuters
·
Aug 06

Collegium Pharmaceutical Q2 Adj. EPS $1.92 Beats $1.72 Estimate, Sales $199.878M Miss $201.206M Estimate

Benzinga Earnings
·
Aug 06

Collegium Pharmaceutical Q2 Adjusted EPS USD 1.92 VS. Ibes Estimate USD 1.72

THOMSON REUTERS
·
Aug 06